Jynarque, JYNARQUE
- Manufacturer
- Otsuka
- ICD-10 indication
- Q61.3
Affordability Check
How much will you actually pay for Jynarque, JYNARQUE?
In 30 seconds, see every legitimate way to afford Jynarque, JYNARQUE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Jynarque, JYNARQUE
What is this medication?
Jynarque is a prescription medicine that contains the active ingredient tolvaptan. It is specifically indicated to slow the decline of kidney function in adults who are at risk of rapidly progressing autosomal dominant polycystic kidney disease, often referred to as ADPKD. This genetic condition is characterized by the development of numerous fluid-filled cysts in the kidneys, which can cause the organs to enlarge and eventually lead to kidney failure. By slowing the rate of kidney function decline, the medication helps manage the progression of this chronic disease.
The medication works by acting as a selective vasopressin V2-receptor antagonist, which helps to reduce the growth and formation of kidney cysts. Because Jynarque carries a risk of serious and potentially fatal liver injury, it is only available through a restricted distribution program called the Jynarque REMS. Patients must undergo regular blood tests to monitor their liver health before and during treatment. Common side effects associated with the drug include increased thirst, frequent urination, and needing to urinate more often during the night.
Copay & patient assistance
- Patient Copay Amount: As little as $0 per 28-day supply
- Maximum Annual Benefit Limit: $9,200 (for 2025)
- Core Eligibility Restrictions: Must have commercial insurance; not eligible if covered by any state or federal healthcare program (including Medicare Part D, Medicaid, Medigap, VA, DOD, or TRICARE); must be 18 years of age or older; must be a resident of the U.S. or Puerto Rico; cannot be combined with other offers or pharmacy benefit manager programs like "maximizers" or "accumulators"; specific state exclusions apply to Massachusetts (starting May 13, 2025) and California (starting August 13, 2025)
- RxBIN, PCN, and Group numbers: Not Publicly Available (A physical copay card is not required as the benefit is applied directly through REMS-certified Specialty Pharmacies)
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Jynarque, JYNARQUE.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Jynarque, JYNARQUE →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Jynarque, JYNARQUE →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
Related drugs
EXTRANEAL
Treats same condition · icodextrin, sodium chloride, sodium lactate, calcium chloride, magnesium chloride
Monoferric
Treats same condition · Ferric derisomaltose
olmesartan medoxomil-hydrochlorothiazide
Treats same condition · olmesartan medoxomil-hydrochlorothiazide
Epaned
Treats same condition · enalapril maleate
DAPAGLIFLOZIN
Treats same condition · DAPAGLIFLOZIN
Exforge HCT
Treats same condition · amlodipine valsartan and hydrochlorothiazide
Amlodipine, Valsartan and Hydrochlorothiazide
Treats same condition · Amlodipine, Valsartan and Hydrochlorothiazide
Amlodipine besylate and Olmesartran medoxomil
Treats same condition · Amlodipine besylate and Olmesartran medoxomil
Calcium Acetate
Treats same condition · Calcium Acetate
Kerendia
Treats same condition · finerenone
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.